Renhe Pharmacy Co

Renhe Pharmacy Co Debt

The Debt of Renhe Pharmacy Co (000650.SZ) as of Oct 29, 2026 is 1.89 M CNY. In the previous year, Debt was 18.50 M CNY — a change of -89.79% (lower).

Debt

1.89 MCNY

YoY

-89.79%

Last updated:

In 2024, Renhe Pharmacy Co's total debt was 1.89 M CNY, a -89.79% change from the 18.50 M CNY total debt recorded in the previous year.

The Renhe Pharmacy Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
0.00 CNY
Jan 1, 2018
182,000.00 CNY
Jan 1, 2019
-73.92 M CNY
Jan 1, 2020
64.44 M CNY
Jan 1, 2021
34.19 M CNY
Jan 1, 2022
34.37 M CNY
Jan 1, 2023
18.50 M CNY
Jan 1, 2024
1.89 M CNY
The Renhe Pharmacy Co Debt history
YEARDebtYoY
1.89 MCNY-89.79%
18.50 MCNY-46.18%
34.37 MCNY+0.51%
34.19 MCNY-46.94%
64.44 MCNY-187.18%
-73.92 MCNY-40,713.20%
182,000.00CNY—
0.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Renhe Pharmacy Co Stock analysis

What does Renhe Pharmacy Co do? Renhe Pharmacy Co., Ltd. generates revenue through the manufacturing and distribution of pharmaceutical products including capsules, granules, tablets, powder, injections, suppositories, and ointment. The company operates in the domestic market, focusing on medical industrial manufacturing and medical merchandising. Its primary customers are domestic healthcare providers and retail outlets purchasing health-related products for distribution or direct consumer use. The firm's product portfolio spans various dosage forms essential for medical treatment and patient care. The company's business model relies on both wholesale and retail channels within China, serving the domestic pharmaceutical market. Renhe Pharmacy's manufacturing segment produces a wide range of medication forms, while its merchandising division handles the sale of health-related products. This dual approach allows the company to capture value across the pharmaceutical supply chain from production to consumer. Renhe Pharmacy Co., Ltd. serves the Chinese domestic market exclusively, with its operations centered on medical industrial manufacturing and medical merchandising. The company's revenue streams are derived from the sale of its diverse product range to healthcare institutions, pharmacies, and consumers through its retail network. This integrated approach ensures consistent market presence and customer reach within its geographic focus. Renhe Pharmacy Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Renhe Pharmacy Co's Debt Structure

Renhe Pharmacy Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Renhe Pharmacy Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Renhe Pharmacy Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Renhe Pharmacy Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Renhe Pharmacy Co stock

Debt of Renhe Pharmacy Co is 1.89 M CNY in 2024.

Debt of Renhe Pharmacy Co changed from 18.50 M CNY to 1.89 M CNY, representing a -89.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Renhe Pharmacy Co since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Renhe Pharmacy Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Renhe Pharmacy Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Renhe Pharmacy Co